Trabectedin-d3

CAT: 0804-HY-50936SSize: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-50936SSize:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Trabectedin D3 (Ecteinascidin 743 D3) is deuterium labeled Trabectedin. Trabectedin is a tetrahydroisoquinoline alkaloid with potent antitumor activity. Trabectedin binds to the minor groove of DNA, blocks transcription of stress-induced proteins, induces DNA backbone cleavage and cancer cells apoptosis, and increases the generation of ROS in MCF-7 and MDA-MB-453 cells. Trabectedin has tje potential for soft tissue sarcoma and ovarian cancer treatment[1][2][3].
Product Name Alternative
Ecteinascidin 743-d3; ET-743-d3
UNSPSC
12352005
Target
Apoptosis; Isotope-Labeled Compounds; Reactive Oxygen Species (ROS)
Type
Isotope-Labeled Compounds
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
99.08
Solubility
10 mM in DMSO|DMSO : 33.33mg/mL (ultrasonic)
Smiles
CC1=C(OCO2)C2=C([C@H](COC3=O)N4[C@]([C@@H]5SC[C@]63C(C=C(OC([2H])([2H])[2H])C(O)=C7)=C7CCN6)([H])[C@@H]8N(C)[C@@H](CC9=CC(C)=C(OC)C(O)=C98)[C@@H]4O)C5=C1OC(C)=O
Molecular Formula
C39H40D3N3O11S
Molecular Weight
764.86
References & Citations
[1]Takahashi N, et al. Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and NSC 125973 in human breast cancer cell linesin vitro and in vivo. Cancer Res. 2002 Dec 1;62 (23) :6909-15.|[2]Atmaca H, et al. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells. Toxicol Lett. 2013 Jun 20;221 (2) :128-136.|[3]Germano G, et al. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. Cancer Res. 2010 Mar 15;70 (6) :2235-44.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-50936Trabectedin
HY-172664Trabectedin derivative 2
HY-172663A-01Trabectedin derivative 1 (TFA)
HY-172664A-01Trabectedin derivative 2 (TFA)
HY-15398S3-01Vitamin D3-d3
HY-132348S1Granisetron-d3 (1-methyl-d3)
HY-150954SL-Methionine-d3 (S-methyl-d3) Methyl-d3-sulfonium Chloride
HY-W758392(±) -Ipratropium-d3 Bromide (N-methyl-d3)
HY-B1213AS-01Trimipramine-d3 (N-methyl-d3) (maleate)
HY-14541S-01Olanzapine-d3

Alternative Products

CatalogName
MBS387395-01Trabectedin
A12714-1Trabectedin 1mg
A12714-5Trabectedin 5mg
RM-T304001-01Trabectedin Impurity A
A12714-10Trabectedin 10mg
A12714-50Trabectedin 50mg
RM-T304005-01Trabectedin Impurity 5
RM-T304004-01Trabectedin Impurity 4
RM-T304002-01Trabectedin Impurity B
RM-T304006-01Trabectedin Impurity 6

Popular Products